|
|
Article: Wasatch Pharmaceutical Skin Care Announcement: Eczema and Contact Dermatitis.
- Article from:
- Business Wire
- Article date:
- April 26, 1999
CopyrightCOPYRIGHT 1999 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MIDVALE, Utah--(BUSINESS WIRE)--April 26, 1999--
Wasatch Pharmaceutical Inc. (OTC BB:WASP), in a series of announcements concerning skin care, is releasing its report on clinical studies regarding the treatment of Eczema and Contact Dermatitis. In studies conducted over a period of four years with over 200 patients, the results are indicated as follows:
ECZEMA -- Patients in this group ranged in ages from infants to adults in their seventies. Types of Eczema ranged from hand eczema to full body eczema. Symptoms of Eczema are characterized by extreme patches of dry skin, inflammation, itching, measles-like sores and open bleeding cracked skin. For all ...